Healio: Wegovy improves functional class in patients with obesity, heart failure at 1 year Wegovy improves functional class in patients with obesity, heart failure at 1 year Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity. No therapies have ... We were unable to process your request.

Understanding the Context

Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Wegovy improved functional class vs. placebo at 1 year ...

Key Insights

EurekAlert!: New data on effective cardiac resynchronisation in patients with heart failure The New England Journal of Medicine: Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Heart failure affects more than 64 million people worldwide (1%โ€“3% in the general adult population) and its prevalence is projected to increase.